跳至主要内容
临床试验/NCT01820507
NCT01820507终止不适用

Prevention of Post-extubation Respiratory Failure in High Risk Patients by High-flow Conditioned Oxygen Therapy Versus Standard Oxygen Therapy

Althaia Xarxa Assistencial Universitària de Manresa2 个研究点 分布在 1 个国家目标入组 155 人开始时间: 2013年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
155
试验地点
2
主要终点
Respiratory failure after extubation

研究概览

简要总结

Failure of extubation after mechanical ventilation is a frequent and deleterious issue. Main reasons for failure are hypoxemia, secretions retention, lung collapse and excessive work of breathing. Most of this issues can be partly counterbalanced by a device named "High flow conditioned oxygen therapy (HFCO)". Then, our hypothesis is that HFCO may reduce the incidence of respiratory failure after extubation in patients with high risk for failure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 95 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients mechanically ventilated for > 48 hours and at least one of the following:
  • >65 years
  • cardiac failure as the primary indication of mechanical ventilation
  • Chronic Obstructive Pulmonary Disease
  • Severity score (APACHE II >12 points) the extubation day
  • Body Mass Index >30
  • inability to manage respiratory secretions
  • 1 failed spontaneous breathing trial
  • 1 comorbidity
  • 7 days under mechanical ventilation

排除标准

  • <18 years
  • tracheotomized patients
  • recent facial or cervical trauma/surgery
  • active gastro-intestinal bleeding
  • lack of cooperation
  • patients with any failed spontaneous breathing trial because of hypercapnia development.

结局指标

主要结局

Respiratory failure after extubation

时间窗: 72 hours

Severe hypoxemia (PaO2/Fraction of inspired O2 \< 200), hypercapnia (PaCO2 \> 50), respiratory acidosis (arterial pH \< 7.30), severe tachypnea (\>40x')

次要结局

  • Survival(90 days)

研究者

发起方
Althaia Xarxa Assistencial Universitària de Manresa
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rafael Fernandez

Head of Intensive Care Department

Althaia Xarxa Assistencial Universitària de Manresa

研究点 (2)

Loading locations...

相似试验